LeMaitre Vascular, Inc. Forecast, price target & analysts
LeMaitre Vascular, Inc. Target price 2025 - Analyst rating & recommendation
LeMaitre Vascular, Inc. Classifications & Recommendation:
LeMaitre Vascular, Inc. Price Target
| Target Price | $99.00 |
| Price | $99.91 |
| Deviation |
0.91%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target LeMaitre Vascular, Inc. 2026 .
The average LeMaitre Vascular, Inc. target price is $99.00.
This is
0.91%
register free of charge
$117.00
17.11%
register free of charge
$85.00
14.92%
register free of charge
|
|
| A rating was issued by 11 analysts: 7 Analysts recommend LeMaitre Vascular, Inc. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the LeMaitre Vascular, Inc. stock has an average upside potential 2026 of
0.91%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 193.48 | 220.05 |
| 19.69% | 13.73% | |
| EBITDA Margin | 24.09% | 31.42% |
| 0.73% | 30.45% | |
| Net Margin | 15.57% | 19.83% |
| 20.38% | 27.37% |
11 Analysts have issued a sales forecast LeMaitre Vascular, Inc. 2024 . The average LeMaitre Vascular, Inc. sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an LeMaitre Vascular, Inc. EBITDA forecast 2024. The average LeMaitre Vascular, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 LeMaitre Vascular, Inc. Analysts have issued a net profit forecast 2024. The average LeMaitre Vascular, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.34 | 1.94 |
| 44.09% | 44.78% | |
| P/E | 53.09 | |
| EV/Sales | 10.05 |
11 Analysts have issued a LeMaitre Vascular, Inc. forecast for earnings per share. The average LeMaitre Vascular, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the LeMaitre Vascular, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
LeMaitre Vascular, Inc....
Current LeMaitre Vascular, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo | Locked ➜ Locked | Locked | Feb 13 2025 |
| Barrington Research | Locked ➜ Locked | Locked | Nov 01 2024 |
| Oppenheimer | Locked ➜ Locked | Locked | Nov 01 2024 |
| Cantor Fitzgerald | Locked ➜ Locked | Locked | Oct 15 2024 |
| Barrington Research | Locked ➜ Locked | Locked | Sep 20 2024 |
| JMP Securities | Locked ➜ Locked | Locked | Aug 20 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo: Locked ➜ Locked
|
Feb 13 2025 |
|
Locked
Barrington Research: Locked ➜ Locked
|
Nov 01 2024 |
|
Locked
Oppenheimer: Locked ➜ Locked
|
Nov 01 2024 |
|
Locked
Cantor Fitzgerald: Locked ➜ Locked
|
Oct 15 2024 |
|
Locked
Barrington Research: Locked ➜ Locked
|
Sep 20 2024 |
|
Locked
JMP Securities: Locked ➜ Locked
|
Aug 20 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
